FINWIRES · TerminalLIVE
FINWIRES

Great-West's Empower Closes $340-Million Acquisition of Milliman's Retirement Administration Business

By

Great-West Lifeco (GWO.TO) subsidiary Empower closed the $340-million acquisition of Milliman's retirement plan and benefits administration business.

The deal expands Empower's presence in the defined benefit marketplace, advancing its strategy to deliver integrated workplace benefits solutions, Great-West said Wednesday.

The transaction boosts Empower's footprint to over 22-million lives served, over $2.3 trillion in client assets and 96,000 workplace plans, according to Great-West.

"With the completion of the transaction, Empower has added approximately 400 defined benefit plans representing approximately 790,000 participants and US$80 billion in client assets. Empower has also added more than 1,100 defined contribution plans representing approximately 750,000 participants and more than US$50 billion in client assets, as well as 100 health and welfare administration clients serving approximately 100,000 participants," the company said.

Great-West shares closed down C$0.53 to C$88.58 Tuesday on the Toronto Stock Exchange.

Related Articles

Mining & Metals

Alimentation Couche-Tard Q1 Adjusted EPS Rises to $0.90; Revenue Beats FactSet Estimate

Alimentation Couche-Tard (ATD.TO) said after the close Tuesday its fiscal first-quarter adjusted earnings per share rose to $0.90 from $0.78 in the prior-year period.Revenue for the period ended July 19 increased to $21.70 billion in the quarter ended July 19 from $17.35 billion a year earlier, exceeding the FactSet consensus estimate of $20.86 billion.The company also declared a quarterly dividend of C$0.22 per share for the first quarter of fiscal 2027, payable Sept. 25 to shareholders of record as of Sept. 11.Shares of the company closed up C$0.81 to C$84.28 on Toronto Stock Exchange.

$ATD.TO
Mining & Metals

Hammond Power Solutions Hikes Its Quarterly Dividend 5.5% to C$0.29 per Class B Share. The Higher Dividend Will Be Paid Sept. 24 to Shareholders of Record on Sept. 17

$HPS-A.TO
Mining & Metals

Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court

Cipher Pharmaceuticals (CPH.TO) said Tuesday after trade that a New York federal court denied Sun Pharmaceuticals' petition to vacate an arbitrator's ruling concerning the ownership of certain clinical data.The court agreed with the arbitrator that Cipher owned clinical data that was used by Sun to launch a prescription anti-acne medication, Abscoria, in Canada in 2023.The arbitrator had awarded Cipher damages of C$4.2 million, a 15% royalty on net sales of Absorica in Canada from Jan. 1, 2026, and ending on Dec. 31, 2040. Also awarded was 80% of Cipher's out-of-pocket attorneys' fees and certain expenses related to the arbitration process, a statement said.The federal court awarded Cipher interest on the damages and its out-of-pocket attorneys' fees and certain expenses directly related to the arbitration process, at a rate of 9% per annum.Cipher Pharmaceuticals shares closed up C$0.51 at C$14.19 on the Toronto Stock Exchange.

$CPH.TO